French agencies to probe claims of malpractice by former committee members
This article was originally published in Scrip
Executive Summary
France's two main agencies dealing with medicines regulation and health economic evaluations, ANSM and HAS, have begun internal investigations into claims that former senior members of their key committees held secret meetings with pharmaceutical company representatives at which money and gifts exchanged hands in advance of drug approval and reimbursement decisions. The two agencies have said they are also referring the matter to the Public Prosecutor.